Bosch-Barrera J, Estevez-Garcia P, Martin-Martorell P, Sabatier R, et al. ENDOLUNG trial, part II. A phase II study of the Akt/mTOR inhibitor and autophagy inducer ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with squamous non-small cell lung cancer. Lung Cancer 2025;201:108105.
PMID: 39983444